» Articles » PMID: 36364844

The Association Between Gut Microbiome and Pregnancy-Induced Hypertension: A Nested Case-Control Study

Overview
Journal Nutrients
Date 2022 Nov 11
PMID 36364844
Authors
Affiliations
Soon will be listed here.
Abstract

(1) Background: Pregnancy-induced hypertension (PIH) is associated with obvious microbiota dysbiosis in the third trimester of pregnancy. However, the mechanisms behind these changes remain unknown. Therefore, this study aimed to explore the relationship between the gut microbiome in early pregnancy and PIH occurrence. (2) Methods: A nested case-control study design was used based on the follow-up cohort. Thirty-five PIH patients and thirty-five matched healthy pregnant women were selected as controls. The gut microbiome profiles were assessed in the first trimester using metagenomic sequencing. (3) Results: Diversity analyses showed that microbiota diversity was altered in early pregnancy. At the species level, eight bacterial species were enriched in healthy controls: , , , , , , and . Conversely, , and were enriched in PIH patients. The results of functional analysis showed that the changes in these different microorganisms may affect the blood pressure of pregnant women by affecting the metabolism of vitamin K, sphingolipid, lipid acid and glycine. (4) Conclusion: Microbiota dysbiosis in PIH patients begins in the first trimester of pregnancy, and this may be associated with the occurrence of PIH. Bacterial pathway analyses suggest that the gut microbiome might lead to the development of PIH through the alterations of function modules.

Citing Articles

Distinct gut microbial signature and altered short chain fatty acid metabolism at disease onset in a rat preclinical model of superimposed preeclampsia.

Alhasan M, Landa M, Garcia S, Gerlach R, Harb H, Fahlbusch F Sci Rep. 2024; 14(1):32137.

PMID: 39738527 PMC: 11686345. DOI: 10.1038/s41598-024-83981-5.


Scoping Review of Microbiota Dysbiosis and Risk of Preeclampsia.

Jordan M, Amabebe E, Khanipov K, Taylor B Am J Reprod Immunol. 2024; 92(4):e70003.

PMID: 39440917 PMC: 11501047. DOI: 10.1111/aji.70003.


Intestinal flora and pregnancy complications: Current insights and future prospects.

Tian Z, Zhang X, Yao G, Jin J, Zhang T, Sun C Imeta. 2024; 3(2):e167.

PMID: 38882493 PMC: 11170975. DOI: 10.1002/imt2.167.


Research progress on the correlation between gut microbiota and preeclampsia: microbiome changes, mechanisms and treatments.

Zong Y, Wang X, Wang J Front Cell Infect Microbiol. 2023; 13:1256940.

PMID: 38029244 PMC: 10644267. DOI: 10.3389/fcimb.2023.1256940.


Causal relationship association of cheese intake with gestational hypertension and diabetes result from a Mendelian randomization study.

Zhong T, Huang Y, Wang G World J Clin Cases. 2023; 11(30):7318-7328.

PMID: 37969456 PMC: 10643065. DOI: 10.12998/wjcc.v11.i30.7318.


References
1.
Tuovinen S, Eriksson J, Kajantie E, Lahti J, Pesonen A, Heinonen K . Maternal hypertensive disorders in pregnancy and self-reported cognitive impairment of the offspring 70 years later: the Helsinki Birth Cohort Study. Am J Obstet Gynecol. 2012; 208(3):200.e1-9. DOI: 10.1016/j.ajog.2012.12.017. View

2.
Yang F, Chen H, Gao Y, An N, Li X, Pan X . Gut microbiota-derived short-chain fatty acids and hypertension: Mechanism and treatment. Biomed Pharmacother. 2021; 130:110503. DOI: 10.1016/j.biopha.2020.110503. View

3.
Zeng Z, Guo X, Zhang J, Yuan Q, Chen S . modulates the gut microbiota and improves inflammation in type 2 diabetic rats. Food Funct. 2021; 12(15):6809-6820. DOI: 10.1039/d1fo00515d. View

4.
Wang J, Shi Z, Yang J, Wei Y, Wang X, Zhao Y . Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters. Chin Med J (Engl). 2020; 133(9):1057-1065. PMC: 7213634. DOI: 10.1097/CM9.0000000000000734. View

5.
Sakakima Y, Hayakawa A, Nagasaka T, Nakao A . Prevention of hepatocarcinogenesis with phosphatidylcholine and menaquinone-4: in vitro and in vivo experiments. J Hepatol. 2007; 47(1):83-92. DOI: 10.1016/j.jhep.2007.01.030. View